Showing results (21-30 of 412) with videos related to
Sort By:
Pageof 42
British Journal of Haematology|July 6, 2017
Comparative outcomes of immunochemotherapy regimens in Waldenström macroglobulinaemiaAdam J Olszewski, Chang Chen, Roee Gutman, et al.Leukemia & Lymphoma|January 22, 2026
Clinicopathological features and management of IgM multiple myeloma and Waldenstrom macroglobulinemiaShayna Sarosiek, Jorge J Castillo, Zachary R Hunter, et al.British Journal of Haematology|February 19, 2025
Zanubrutinib for the treatment of Bing-Neel syndromeShayna Sarosiek, Andres Ramirez-Gamero, Catherine A Flynn, et al.American Journal of Hematology|July 15, 2016
Histological transformation to diffuse large B-cell lymphoma in patients with Waldenström macroglobulinemiaJorge J Castillo, Joshua Gustine, Kirsten Meid, et al.Hematology/Oncology Clinics of North America|September 8, 2018
Genomic Landscape of Waldenström MacroglobulinemiaSteven P Treon, Lian Xu, Xia Liu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2017
Genomics, Signaling, and Treatment of Waldenström MacroglobulinemiaZachary R Hunter, Guang Yang, Lian Xu, et al.Expert Review of Hematology|July 26, 2019
CXCR4 mutations affect presentation and outcomes in patients with Waldenström macroglobulinemia: A systematic reviewJorge J Castillo, David F Moreno, Maria I Arbelaez, et al.American Journal of Hematology|May 13, 2015
Survival outcomes of secondary cancers in patients with Waldenström macroglobulinemia: An analysis of the SEER databaseJorge J Castillo, Adam J Olszewski, Sandra Kanan, et al.Cancer|March 12, 2015
Incidence of secondary malignancies among patients with Waldenström macroglobulinemia: An analysis of the SEER databaseJorge J Castillo, Adam J Olszewski, Zachary R Hunter, et al.Best Practice & Research. Clinical Haematology|November 10, 2016
Future therapeutic options for patients with Waldenström macroglobulinemiaJorge J Castillo, Zachary R Hunter, Guang Yang, et al.Pageof 42